CELZ logo

Creative Medical Technology Holdings, Inc.

CELZ
Healthcare|Biotechnology|US
$0.62
+0.02 (+2.65%)
DCF Value
$2.94
Tangible Book / Share
$1.05
Cash / Share
$1.03
Next Earnings Report
Mar 19, 2027
EPS est. -$0.24
Financing Filings (last 12 months)
6
Shelf registrations / offering prospectuses — latest Aug 3, 2026 (424B3). Possible dilution.

Upcoming Data Readouts (2)

Jan 2027
Est. completion
P1P2Chronic Low-back Pain
Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back Pain
NCT06053242n=45
Jan 2027
Est. completion
P1P2Type 1 Diabetes
Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes
NCT05626712n=18

Recent Press Releases

Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study
Oct 20, 2026 · GlobeNewsWire
Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing
Sep 17, 2026 · GlobeNewsWire
Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning
Aug 20, 2026 · GlobeNewsWire

SEC Filings (48)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 202610-QQuarterly reportDocumentIndex
Oct 1, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Sep 25, 20268-KMaterial eventDocumentIndex
Aug 31, 20268-KMaterial eventDocumentIndex
Aug 7, 202610-QQuarterly reportDocumentIndex
Aug 3, 2026424B3Offering prospectusDocumentIndex
Jul 31, 2026EFFECTDocumentIndex
Jul 24, 2026S-3Shelf registrationDocumentIndex
Jul 14, 2026DEF 14AProxy / shareholder voteDocumentIndex
Jul 2, 20268-KMaterial eventDocumentIndex
Jul 1, 2026PRE 14AProxy / shareholder voteDocumentIndex
Jun 30, 2026RWDocumentIndex
Jun 26, 2026S-1/AIPO / offering registrationDocumentIndex
Jun 25, 2026S-1IPO / offering registrationDocumentIndex
May 8, 202610-QQuarterly reportDocumentIndex
Apr 24, 202610-K/AAnnual reportDocumentIndex
Mar 20, 202610-KAnnual reportDocumentIndex
Dec 31, 20258-KMaterial eventDocumentIndex
Dec 19, 20258-KMaterial eventDocumentIndex
Dec 16, 2025424B3Offering prospectusDocumentIndex
Dec 12, 2025EFFECTDocumentIndex
Nov 21, 2025S-3Shelf registrationDocumentIndex
Nov 13, 2025DEF 14AProxy / shareholder voteDocumentIndex
Nov 12, 20258-KMaterial eventDocumentIndex
Nov 7, 202510-QQuarterly reportDocumentIndex
Nov 3, 2025PRE 14AProxy / shareholder voteDocumentIndex
Oct 31, 20258-KMaterial eventDocumentIndex
Oct 30, 2025DEF 14AProxy / shareholder voteDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 8, 202510-QQuarterly reportDocumentIndex
May 15, 2025SC 13GPassive 5%+ stakeDocumentIndex
May 9, 202510-QQuarterly reportDocumentIndex
May 6, 20258-KMaterial eventDocumentIndex
Apr 25, 202510-K/AAnnual reportDocumentIndex
Apr 15, 2025424B3Offering prospectusDocumentIndex
Apr 11, 2025EFFECTDocumentIndex
Apr 11, 20258-KMaterial eventDocumentIndex
Apr 4, 202510-K/AAnnual reportDocumentIndex
Apr 2, 2025S-3Shelf registrationDocumentIndex
Mar 19, 202510-K/AAnnual reportDocumentIndex